FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. It operates through the FOXO Labs and FOXO Life segments. The FOXO Labs segment is involved in research and development and is commercializing proprietary epigenetic biomarker technology. The FOXO Life segment is involved in combining life insurance with a dynamic molecular health and wellness platform. The company was founded on April 27, 2020 and is headquartered in West Palm Beach, FL.
Sector:
Technology Services
Industry:
Packaged Software
Employees:
N/A
Frequently Asked Questions
What is Market Cap of FOXO Technologies Inc - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. FOXO Technologies Inc - Ordinary Shares - Class A market cap is $3,063.00.
What is the 52-week high for FOXO Technologies Inc - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. FOXO Technologies Inc - Ordinary Shares - Class A 52 week high is $4.74 as of March 28, 2026.
What is the 50-day moving average of FOXO Technologies Inc - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. FOXO Technologies Inc - Ordinary Shares - Class A 50-day moving average is $0.0001.